176 related articles for article (PubMed ID: 19272137)
1. Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study.
Szachnowicz S; Cecconello I; Ribeiro U; Iriya K; El Ibrahim R; Takeda FR; Corbett CE; Vaz Safatle-Ribeiro A
World J Surg Oncol; 2009 Mar; 7():27. PubMed ID: 19272137
[TBL] [Abstract][Full Text] [Related]
2. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
3. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
[TBL] [Abstract][Full Text] [Related]
4. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
5. Gastric and intestinal differentiation in Barrett's metaplasia and associated adenocarcinoma.
Chaves P; Cruz C; Dias Pereira A; Suspiro A; de Almeida JC; Leitão CN; Soares J
Dis Esophagus; 2005; 18(6):383-7. PubMed ID: 16336609
[TBL] [Abstract][Full Text] [Related]
6. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
7. Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.
Burjonrappa SC; Reddimasu S; Nawaz Z; Gao X; Sharma P; Loggie B
Indian J Cancer; 2007; 44(1):1-5. PubMed ID: 17401217
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.
Warson C; Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Ectors NL; Dekker J
Hum Pathol; 2002 Jun; 33(6):660-8. PubMed ID: 12152167
[TBL] [Abstract][Full Text] [Related]
9. Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma.
Endo T; Tamaki K; Arimura Y; Itoh F; Hinoda Y; Hareyama M; Irimura T; Fujita M; Imai K
J Gastroenterol; 1998 Dec; 33(6):811-5. PubMed ID: 9853552
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression and cell proliferation are increased in MUC2-positive area of columnar-lined esophagus.
Jang TJ; Cho MY
Pathol Int; 2005 Sep; 55(9):546-9. PubMed ID: 16143029
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic differences between esophageal and gastric intestinal metaplasia.
Piazuelo MB; Haque S; Delgado A; Du JX; Rodriguez F; Correa P
Mod Pathol; 2004 Jan; 17(1):62-74. PubMed ID: 14631367
[TBL] [Abstract][Full Text] [Related]
12. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
[TBL] [Abstract][Full Text] [Related]
13. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
[TBL] [Abstract][Full Text] [Related]
14. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
15. Origin of adenocarcinoma in Barrett's esophagus: p53 and Ki67 expression and histopathologic background.
Szachnowicz S; Cecconello I; Iriya K; Marson AG; Takeda FR; Gama-Rodrigues JJ
Clinics (Sao Paulo); 2005 Apr; 60(2):103-12. PubMed ID: 15880245
[TBL] [Abstract][Full Text] [Related]
16. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
17. Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation.
Chaves P; Cardoso P; de Almeida JC; Pereira AD; Leitao CN; Soares J
Hum Pathol; 1999 Nov; 30(11):1291-5. PubMed ID: 10571507
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan.
Azuma N; Endo T; Arimura Y; Motoya S; Itoh F; Hinoda Y; Irimura T; Hosokawa M; Imai K
J Gastroenterol; 2000; 35(8):583-92. PubMed ID: 10955596
[TBL] [Abstract][Full Text] [Related]
19. Foveolar type dysplasia in Barrett esophagus.
Brown IS; Whiteman DC; Lauwers GY
Mod Pathol; 2010 Jun; 23(6):834-43. PubMed ID: 20228780
[TBL] [Abstract][Full Text] [Related]
20. Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study.
Arul GS; Moorghen M; Myerscough N; Alderson DA; Spicer RD; Corfield AP
Gut; 2000 Dec; 47(6):753-61. PubMed ID: 11076872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
